Improving social function with real-world social-cognitive remediation in schizophrenia: Results from the RemedRugby quasi-experimental trial.
Physical activity
schizophrenia
social cognitive remediation
social function
touchrugby
Journal
European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820
Informations de publication
Date de publication:
30 04 2020
30 04 2020
Historique:
pubmed:
1
5
2020
medline:
12
1
2021
entrez:
1
5
2020
Statut:
epublish
Résumé
Functional capacity (FC) has been identified as a key outcome to improve real-world functioning in schizophrenia. FC is influenced by cognitive impairments, negative symptoms, self-stigma and reduced physical activity (PA). Psychosocial interventions targeting FC are still under-developed. we conducted a quasi-experimental study evaluating the effects of an exercise-enriched integrated social cognitive remediation (SCR) intervention (RemedRugby [RR]) compared with an active control group practicing Touch Rugby (TR). To our knowledge, this is the first trial to date evaluating the effectiveness of such a program provided in a real-life environment. Eighty-seven people with schizophrenia were included and allocated to either the RR group (n = 57) or the TR group (n = 30) according to the routine clinical practice of the recruiting center. Outcomes were evaluated at baseline and post-treatment in both groups and after 6 months of follow-up in the RR group using standardized scales for symptom severity, social functioning, self-stigma, and a large cognitive battery. After treatment we observed moderate to large improvements in social function (Personal and Social Performance Scale [PSP], p < 0.001, d = 1.255), symptom severity (Positive and Negative Syndrome Scale [PANSS] negative, p < 0.001, d = 0.827; PANSS GP, p < 0.001, d = 0.991; PANSS positive, p = 0.009, d = 0.594), verbal abstraction (p = 0.008, d = 0.554), aggression bias (p = 0.008, d = 0.627), and self-stigma (stereotype endorsement, p = 0.019, d = 0.495; discrimination experiences, p = 0.047; d = 0.389) that were specific to the RR group and were not observed in participants playing only TR. Effects were persistent over time and even larger between post-treatment and follow-up. Exercise-enriched integrated SCR appears promising to improve real-life functioning in schizophrenia. Future research should investigate the potential effects of this intervention on neuroplasticity and physical fitness.
Sections du résumé
BACKGROUND
Functional capacity (FC) has been identified as a key outcome to improve real-world functioning in schizophrenia. FC is influenced by cognitive impairments, negative symptoms, self-stigma and reduced physical activity (PA). Psychosocial interventions targeting FC are still under-developed.
METHODS
we conducted a quasi-experimental study evaluating the effects of an exercise-enriched integrated social cognitive remediation (SCR) intervention (RemedRugby [RR]) compared with an active control group practicing Touch Rugby (TR). To our knowledge, this is the first trial to date evaluating the effectiveness of such a program provided in a real-life environment.
RESULTS
Eighty-seven people with schizophrenia were included and allocated to either the RR group (n = 57) or the TR group (n = 30) according to the routine clinical practice of the recruiting center. Outcomes were evaluated at baseline and post-treatment in both groups and after 6 months of follow-up in the RR group using standardized scales for symptom severity, social functioning, self-stigma, and a large cognitive battery. After treatment we observed moderate to large improvements in social function (Personal and Social Performance Scale [PSP], p < 0.001, d = 1.255), symptom severity (Positive and Negative Syndrome Scale [PANSS] negative, p < 0.001, d = 0.827; PANSS GP, p < 0.001, d = 0.991; PANSS positive, p = 0.009, d = 0.594), verbal abstraction (p = 0.008, d = 0.554), aggression bias (p = 0.008, d = 0.627), and self-stigma (stereotype endorsement, p = 0.019, d = 0.495; discrimination experiences, p = 0.047; d = 0.389) that were specific to the RR group and were not observed in participants playing only TR. Effects were persistent over time and even larger between post-treatment and follow-up.
CONCLUSIONS
Exercise-enriched integrated SCR appears promising to improve real-life functioning in schizophrenia. Future research should investigate the potential effects of this intervention on neuroplasticity and physical fitness.
Identifiants
pubmed: 32349835
doi: 10.1192/j.eurpsy.2020.42
pii: S0924933820000425
pmc: PMC7355162
doi:
Types de publication
Controlled Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e41Références
Schizophr Bull. 2016 Jul;42 Suppl 1:S44-52
pubmed: 27460618
Psychiatr Serv. 1997 Aug;48(8):1042-7
pubmed: 9255837
World Psychiatry. 2011 Feb;10(1):52-77
pubmed: 21379357
Schizophr Res. 2009 May;110(1-3):165-72
pubmed: 19230622
Early Interv Psychiatry. 2019 Aug;13(4):745-751
pubmed: 29602244
World Psychiatry. 2014 Oct;13(3):275-87
pubmed: 25273301
Clin Psychol Rev. 2017 Mar;52:43-51
pubmed: 27930934
Schizophr Bull. 2010 Jan;36(1):48-70
pubmed: 19955389
Psychiatry Res. 2003 Nov 1;121(1):31-49
pubmed: 14572622
Psychiatry Res. 2017 Sep;255:292-296
pubmed: 28600998
J Nerv Ment Dis. 2020 Feb;208(2):138-142
pubmed: 31821215
Psychol Med. 2015 May;45(7):1343-61
pubmed: 25650668
JAMA Psychiatry. 2018 Apr 1;75(4):396-404
pubmed: 29450447
Acta Psychiatr Scand. 2012 May;125(5):352-62
pubmed: 22176559
Int Rev Psychiatry. 2010;22(2):114-29
pubmed: 20504052
J Autism Dev Disord. 2006 Jul;36(5):623-36
pubmed: 16755332
Eur Neuropsychopharmacol. 2018 Jan;28(1):24-36
pubmed: 29301707
Qual Life Res. 2008 Dec;17(10):1247-56
pubmed: 18855124
Schizophr Bull. 2020 Feb 26;46(2):236-241
pubmed: 31598707
Schizophr Bull. 2013 Nov;39(6):1296-306
pubmed: 23172003
Psychiatry Res. 2006 Jun 30;143(1):99-108
pubmed: 16725210
Schizophr Res Cogn. 2018 Nov 08;15:21-29
pubmed: 30534527
Neuropsychiatr Dis Treat. 2013;9:595-603
pubmed: 23662058
World Psychiatry. 2012 Jun;11(2):73-9
pubmed: 22654932
Compr Psychiatry. 2014 Jan;55(1):221-31
pubmed: 24060237
Schizophr Res. 2017 Jul;185:161-166
pubmed: 28089135
Clin Schizophr Relat Psychoses. 2010 Apr;4(1):41-8
pubmed: 20643628
Curr Med Res Opin. 2009 Feb;25(2):325-38
pubmed: 19192977
Schizophr Res. 2018 Jul;197:124-130
pubmed: 29395609
Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):972-80
pubmed: 17054565
Schizophr Res. 2015 Mar;162(1-3):35-41
pubmed: 25640526
Schizophr Res. 2013 Oct;150(1):58-63
pubmed: 23993864
Psychiatry Res. 2013 Jan 30;205(1-2):43-7
pubmed: 22995038
Schizophr Res. 2020 Jan;215:49-53
pubmed: 31699627
J Consult Clin Psychol. 2008 Jun;76(3):491-504
pubmed: 18540742
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Depress Anxiety. 2013 Aug;30(8):757-62
pubmed: 23532913
Schizophr Bull. 2014 Mar;40(2):314-26
pubmed: 24493852
Schizophr Bull. 2017 May 1;43(3):546-556
pubmed: 27521348
Schizophr Bull. 2015 Jul;41(4):847-58
pubmed: 25782770
Early Interv Psychiatry. 2015 Apr;9(2):133-40
pubmed: 25775264
Schizophr Res. 2015 Oct;168(1-2):267-72
pubmed: 26164820
Soc Sci Med. 2010 Dec;71(12):2150-61
pubmed: 21051128
Front Psychiatry. 2019 Nov 21;10:847
pubmed: 31824350
Schizophr Bull. 2018 Oct 17;44(6):1235-1244
pubmed: 29267940
Eur Arch Psychiatry Clin Neurosci. 2019 Aug;269(5):599-610
pubmed: 30963264
Psychol Med. 2016 Oct;46(14):2869-2881
pubmed: 27502153
Psychiatry Res. 2008 Nov 30;161(2):213-24
pubmed: 18848731
J Pers Assess. 2011 Jan;93(1):84-95
pubmed: 21184334
World Psychiatry. 2019 Jun;18(2):146-161
pubmed: 31059632
Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):285-294
pubmed: 27381016
Schizophr Res. 2016 Jun;173(3):182-191
pubmed: 25623601
Clin Psychol Rev. 2016 Feb;43:80-9
pubmed: 26437567
Cogn Neuropsychiatry. 2007 Mar;12(2):128-43
pubmed: 17453895
Compr Psychiatry. 2014 May;55(4):792-8
pubmed: 24582272
Schizophr Bull. 2013 Sep;39(5):979-92
pubmed: 22949733
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Psychiatry Res. 2013 Apr 30;206(2-3):151-7
pubmed: 23218915
Psychiatr Serv. 2019 Apr 1;70(4):316-323
pubmed: 30691384
Schizophr Res. 2011 Sep;131(1-3):133-8
pubmed: 21669512